Effect of Sphingosine-1-Phosphate on Intracellular Free Ca2+ in Cat Esophageal Smooth Muscle Cells |
Lee, Dong Kyu
(Department of Pharmacology, College of Pharmacy, Chung-Ang University)
Min, Young Sil (Department of Pharmaceutical Engineering, College of Convergence Science and Technology, Jung Won University) Yoo, Seong Su (Department of Pharmacology, College of Pharmacy, Chung-Ang University) Shim, Hyun Sub (Department of Pharmacology, College of Pharmacy, Chung-Ang University) Park, Sun Young (Department of Pharmacology, College of Pharmacy, Chung-Ang University) Sohn, Uy Dong (Department of Pharmacology, College of Pharmacy, Chung-Ang University) |
1 | Matula, K., Collie-Duguid, E., Murray, G., Parikh, K., Grabsch, H., Tan, P., Lalwani, S., Garau, R., Ong, Y., Bain, G., Smith, A. D., Urquhart, G., Bielawski, J., Finnegan, M. and Petty, R. (2015) Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer. BMC Cancer 15, 762. DOI |
2 | Milara, J., Mata, M., Mauricio, M. D., Donet, E., Morcillo, E. J. and Cortijo, J. (2009) Sphingosine-1-phosphate increases human alveolar epithelial IL-8 secretion, proliferation and neutrophil chemotaxis. Eur. J. Pharmacol. 609, 132-139. DOI |
3 | Nema, R., Vishwakarma, S., Agarwal, R., Panday, R. K. and Kumar, A. (2016) Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinoma. Onco Targets Ther. 9, 3269-3280. |
4 | Ng, M. L., Wadham, C. and Sukocheva, O. A. (2017) The role of sphingolipid signalling in diabetesassociated pathologies (Review). Int. J. Mol. Med. 39, 243-252. DOI |
5 | Nishimura, N., Endo, S., Ueno, S., Ueno, N., Tatetsu, H., Hirata, S., Hata, H., Komohara, Y., Takeya, M., Mitsuya, H. and Okuno, Y. (2017) A xenograft model reveals that PU.1 functions as a tumor suppressor for multiple myeloma in vivo. Biochem. Biophys. Res. Commun. 486, 916-922. DOI |
6 | Patmanathan, S. N., Wang, W., Yap, L. F., Herr, D. R. and Paterson, I. C. (2017) Mechanisms of sphingosine 1-phosphate receptor signalling in cancer. Cell Signal. 34, 66-75. DOI |
7 | Puli, M. R., Rajsheel, P., Aswani, V., Agurla, S., Kuchitsu, K. and Raghavendra, A. S. (2016) Stomatal closure induced by phytosphingosine-1-phosphate and sphingosine-1-phosphate depends on nitric oxide and pH of guard cells in Pisum sativum. Planta 244, 831-841. DOI |
8 | Qiu, W. and Steinberg, S. F. (2016) Phos-tag SDS-PAGE resolves agonist-and isoform-specific activation patterns for PKD2 and PKD3 in cardiomyocytes and cardiac fibroblasts. J. Mol. Cell. Cardiol. 99, 14-22. DOI |
9 | Ruger, K., Ottenlinger, F., Schroder, M., Zivkovic, A., Stark, H., Pfeilschifter, J. M. and Radeke, H. H. (2014) Modulation of IL-33/ST2-TIR and TLR signalling pathway by fingolimod and analogues in immune cells. Scand. J. Immunol. 80, 398-407. DOI |
10 | Selli, C. and Tosun, M. (2016) Effects of cyclopiazonic acid and dexamethasone on serotonin-induced calcium responses in vascular smooth muscle cells. J. Physiol. Biochem. 72, 245-253. DOI |
11 | Serafimidis, I., Rodriguez-Aznar, E., Lesche, M., Yoshioka, K., Takuwa, Y., Dahl, A., Pan, D. and Gavalas, A. (2017) Pancreas lineage allocation and specification are regulated by sphingosine-1-phosphate signalling. PLoS Biol. 15, e2000949. DOI |
12 | Shaifta, Y., Snetkov, V. A., Prieto-Lloret, J., Knock, G. A., Smirnov, S. V., Aaronson, P. I. and Ward, J. P. (2015) Sphingosylphosphorylcholine potentiates vasoreactivity and voltage-gated Ca2+ entry via NOX1 and reactive oxygen species. Cardiovasc. Res. 106, 121-130. DOI |
13 | Simo-Cheyou, E. R., Tan, J. J., Grygorczyk, R. and Srivastava, A. K. (2017) STIM-1 and ORAI-1 channel mediate angiotensin-II-induced expression of Egr-1 in vascular smooth muscle cells. J. Cell. Physiol. 232, 3496-3509. DOI |
14 | Sohn, U. D., Hong, Y. W., Choi, H. C., Ha, J. H., Lee, K. Y., Kim, W. J., Biancani, P., Jeong, J. H. and Huh, I. H. (2000) Increase of [Ca(2+)] i and release of arachidonic acid via activation of M2 receptor coupled to Gi and rho proteins in oesophageal muscle. Cell Signal. 12, 215-222. DOI |
15 | Wetter, J. A., Revankar, C. and Hanson, B. J. (2009) Utilization of the Tango beta-arrestin recruitment technology for cell-based EDG receptor assay development and interrogation. J. Biomol. Screen. 14, 1134-1141. DOI |
16 | Sysol, J. R., Natarajan, V. and Machado, R. F. (2016) PDGF induces SphK1 expression via Egr-1 to promote pulmonary artery smooth muscle cell proliferation. Am. J. Physiol. Cell Physiol. 310, C983-C992. DOI |
17 | Tafelmeier, M., Fischer, A., Orso, E., Konovalova, T., Bottcher, A., Liebisch, G., Matysik, S. and Schmitz, G. (2017) Mildly oxidized HDL decrease agonist-induced platelet aggregation and release of procoagulant platelet extracellular vesicles. J. Steroid. Biochem. Mol. Biol. 169, 176-188. DOI |
18 | Terada, S., Muraoka, I. and Tabata, I. (2003) Changes in [Ca2+]i induced by several glucose transport-enhancing stimuli in rat epitrochlearis muscle. J. Appl. Physiol. 94, 1813-1820. DOI |
19 | Vestri, A., Pierucci, F., Frati, A., Monaco, L. and Meacci, E. (2017) Sphingosine 1-phosphate receptors: do they have a therapeutic potential in cardiac fibrosis? Front. Pharmacol. 8, 296. DOI |
20 | Vyas, V., Ashby, C. R., Jr., Olgun, N. S., Sundaram, S., Salami, O., Munnangi, S., Pekson, R., Mahajan, P. and Reznik, S. E. (2015) Inhibition of sphingosine kinase prevents lipopolysaccharide-induced preterm birth and suppresses proinflammatory responses in a murine model. Am. J. Pathol. 185, 862-869. DOI |
21 | Yamazaki, Y., Kon, J., Sato, K., Tomura, H., Sato, M., Yoneya, T., Okazaki, H., Okajima, F. and Ohta, H. (2000) Edg-6 as a putative sphingosine 1-phosphate receptor coupling to signaling pathway. Biochem. Biophys. Res. Commun. 268, 583-589. DOI |
22 | Bates, R. C., Fees, C. P., Holland, W. L., Winger, C. C., Batbayar, K., Ancar, R., Bergren, T., Petcoff, D. and Stith, B. J. (2014) Activation of Src and release of intracellular calcium by phosphatidic acid during Xenopus laevis fertilization. Dev. Biol. 386, 165-180. DOI |
23 | Yates, S. L., Fluhler, E. N. and Lippiello, P. M. (1992) Advances in the use of the fluorescent probe fura-2 for the estimation of intrasynaptosomal calcium. J. Neurosci. Res. 32, 255-260. DOI |
24 | Yu, X., Wang, X., Huang, X., Buchenauer, H., Han, Q., Guo, J., Zhao, J., Qu, Z., Huang, L. and Kang, Z. (2011) Cloning and characterization of a wheat neutral ceramidase gene Ta-CDase. Mol. Biol. Rep. 38, 3447-3454. DOI |
25 | Zhai, L., Wu, R., Han, W., Zhang, Y. and Zhu, D. (2017) miR-127 enhances myogenic cell differentiation by targeting S1PR3. Cell Death Dis. 8, e2707. DOI |
26 | Adamson, R. H., Sarai, R. K., Clark, J. F., Altangerel, A., Thirkill, T. L. and Curry, F. E. (2012) Attenuation by sphingosine-1-phosphate of rat microvessel acute permeability response to bradykinin is rapidly reversible. Am. J. Physiol. Heart Circ. Physiol. 302, H1929-H1935. DOI |
27 | Ahmed, D., de Verdier, P. J., Ryk, C., Lunqe, O., Stal, P. and Flygare, J. (2015) FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity. Pharmacol. Res. Perspect. 3, e00171. DOI |
28 | Aoyama, Y., Sobue, S., Mizutani, N., Inoue, C., Kawamoto, Y., Nishizawa, Y., Ichihara, M., Kyogashima, M., Suzuki, M., Nozawa, Y. and Murate, T. (2017) Modulation of the sphingolipid rheostat is involved in paclitaxel resistance of the human prostate cancer cell line PC3-PR. Biochem. Biophys. Res. Commun. 486, 551-557. DOI |
29 | Archbold, J. K., Martin, J. L. and Sweet, M. J. (2014) Towards selective lysophospholipid GPCR modulators. Trends Pharmacol. Sci. 35, 219-226. DOI |
30 | Badawy, S. M. M., Okada, T., Kajimoto, T., Ijuin, T. and Nakamura, S. I. (2017) DHHC5-mediated palmitoylation of S1P receptor subtype 1 determines G-protein coupling. Sci. Rep. 7, 16552. DOI |
31 | Becker, S., Kinny-Koster, B., Bartels, M., Scholz, M., Seehofer, D., Berg, T., Engelmann, C., Thiery, J., Ceglarek, U. and Kaiser, T. (2017) Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis. PLoS ONE 12, e0174424. DOI |
32 | Biancani, P., Hillemeier, C., Bitar, K. N. and Makhlouf, G. M. (1987) Contraction mediated by Ca2+ influx in esophageal muscle and by Ca2+ release in the LES. Am. J. Physiol. 253, G760-G766. |
33 | Candalija, A., Cubi, R., Ortega, A., Aguilera, J. and Gil, C. (2014) Trk receptors need neutral sphingomyelinase activity to promote cell viability. FEBS Lett. 588, 167-174. DOI |
34 | Choi, S. K., Ahn, D. S. and Lee, Y. H. (2009) Comparison of contractile mechanisms of sphingosylphosphorylcholine and sphingosine-1-phosphate in rabbit coronary artery. Cardiovasc. Res. 82, 324-332. |
35 | Fuhrmann, I. K., Steinhagen, J., Ruther, W. and Schumacher, U. (2015) Comparative immunohistochemical evaluation of the zonal distribution of extracellular matrix and inflammation markers in human meniscus in osteoarthritis and rheumatoid arthritis. Acta Histochem. 117, 243-254. DOI |
36 | Cui, K., Ruan, Y., Wang, T., Rao, K., Chen, Z., Wang, S. and Liu, J. (2017) FTY720 supplementation partially improves erectile dysfunction in rats with streptozotocin-induced type 1 diabetes through inhibition of endothelial dysfunction and corporal fibrosis. J. Sex. Med. 14, 323-335. DOI |
37 | Delgado, A. and Martinez-Cartro, M. (2016) Therapeutic potential of the modulation of sphingosine-1-phosphate receptors. Curr. Med. Chem. 23, 242-264. DOI |
38 | Dyckman, A. J. (2017) Modulators of sphingosine-1-phosphate pathway biology: recent advances of Sphingosine-1-phosphate Receptor 1 (S1P1) agonists and future perspectives. J. Med. Chem. 60, 5267-5289. DOI |
39 | Feuerborn, R., Becker, S., Poti, F., Nagel, P., Brodde, M., Schmidt, H., Christoffersen, C., Ceglarek, U., Burkhardt, R. and Nofer, J.R. (2017) High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expression. Atherosclerosis 257, 29-37. DOI |
40 | Filipenko, I., Schwalm, S., Reali, L., Pfeilschifter, J., Fabbro, D., Huwiler, A. and Zangemeister-Wittke, U. (2016) Upregulation of the S1P3 receptor in metastatic breast cancer cells increases migration and invasion by induction of PGE2 and EP2/EP4 activation. Biochim. Biophys. Acta 1861, 1840-1851. DOI |
41 | Germinario, E., Bondi, M., Cencetti, F., Donati, C., Nocella, M., Colombini, B., Betto, R., Bruni, P., Bagni, M. A. and Danieli-Betto, D. (2016) S1P3 receptor influences key physiological properties of fast-twitch extensor digitorum longus muscle. J. Appl. Physiol. 120, 1288-1300. DOI |
42 | Li, Q., Chen, B., Zeng, C., Fan, A., Yuan, Y., Guo, X., Huang, X. and Huang, Q. (2015) Differential activation of receptors and signal pathways upon stimulation by different doses of sphingosine-1-phosphate in endothelial cells. Exp. Physiol. 100, 95-107. DOI |
43 | Hohenhaus, D. M., Schaale, K., Le Cao, K. A., Seow, V., Iyer, A., Fairlie, D. P. and Sweet, M. J. (2013) An mRNA atlas of G protein-coupled receptor expression during primary human monocyte/macrophage differentiation and lipopolysaccharide-mediated activation identifies targetable candidate regulators of inflammation. Immunobiology 218, 1345-1353. DOI |
44 | Kanemura, N., Shibata, R., Ohashi, K., Ogawa, H., Hiramatsu-Ito, M., Enomoto, T., Yuasa, D., Ito, M., Hayakawa, S., Otaka, N., Murohara, T. and Ouchi, N. (2017) C1q/TNF-related protein 1 prevents neointimal formation after arterial injury. Atherosclerosis 257, 138-145. DOI |
45 | Li, N. and Zhang, F. (2016) Implication of sphingosin-1-phosphate in cardiovascular regulation. Front. Biosci. (Landmark Ed.) 21, 1296-1313. DOI |
46 | Li, S., Chen, J., Fang, X. and Xia, X. (2017) Sphingosine-1-phosphate activates the AKT pathway to inhibit chemotherapy induced human granulosa cell apoptosis. Gynecol. Endocrinol. 33, 476-479. DOI |
47 | Liu, P., Hopfner, R. L., Xu, Y. J. and Gopalakrishnan, V. (1999) Vasopressin-evoked [Ca2+]i responses in neonatal rat cardiomyocytes. J. Cardiovasc. Pharmacol. 34, 540-546. DOI |
48 | Gomez-Munoz, A., Gangoiti, P., Granado, M. H., Arana, L. and Ouro, A. (2010) Ceramide-1-phosphate in cell survival and inflammatory signaling. Adv. Exp. Med. Biol. 688, 118-130. |